Category Archives: Clinical Pharmacokinetics

Vortioxetine pharmacokinetics, writ small and large


This review of the pharmacokinetics of vortioxetine (G. Chen and colleagues, Clinical Pharmacokinetics 57:6:673-686, 2018), approved for treatment of depression and withal alleged to enhance cognition by increasing alertness, reminds us of how useful clinically can be knowing how long it takes for peak blood concentrations to fall by half (elimination half-life), how long is required for drug blood … Read the rest